Come up with a name for your new list and we'll add to it:
ARMO BioSciences raised a round of funding on May 10, 2018. Investors include
Eli Lilly & Co..
ARMO BioSciences is focused on developing immunotherapies for the treatment of cancer, fibrosis, hypercholesterolemia/atherosclerosis and inflammatory diseases. ARMO believes that by harnessing the bo…